Search Videos and More
Pulmonary Hypertension: An update on diagnosis, treatment and risk assessment
Pulmonary hypertension encompasses a broad scope of disease states. This program will focus on pulmonary arterial hypertension (PAH) which begins as a vasculopathy within the small pulmonary arteries.Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.Diaphragm Dysfunction
While respiratory muscle dysfunction is well-documented, it’s often an underdiagnosed cause of dyspnea, and requires a multidisciplinary approach. Sources range from focal diaphragm dysfunction to systemic neuromuscular disease, often with overlooked symptoms and delayed diagnosis. This CME activity is divided into three sections, with a focus on general approach and diagnostic modalities for patients with suspected respiratory muscle impairment, surgical interventions for unilateral diaphragm dysfunction, and evaluation and treatment of systemic neuromuscular diseases.Lung Cancer Screening and SPN in the Patient with COPD
Patients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.Bronchoscopic Lung Volume Reduction - A conversation with national expert - Gerard J. Criner, MD - Podcast recorded by the American Association for Bronchology & International Pulmonology
In this podcast recorded by the American Association of Bronchology and Interventional Pulmonology, Gerard J. Criner, MD discusses patient selection for Bronchoscopic Lung Volume Reduction.Targeted Lung Denervation
Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.Role of Chest Imaging in Bronchoscopic Lung Volume Reduction Using Endobronchial Valves
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and morbidity worldwide.New Treatment Pathways for Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN, also known as neonatal pulmonary hypertension and persistent fetal circulation syndrome), affects 2% of live births and is a major cause of neonatal mortality.Case Study: Elevated Hemidiaphragm
A 60-year-old man with multiple co-morbidities presented for evaluation of dyspnea.Humidified Nasal High-Flow Therapy May Be an Effective At-Home Treatment for COPD
A pilot study at Temple suggests that daily use of humidified nasal high-flow (NHF) therapy with an air-oxygen blend as a maintenance therapy could benefit patients discharged from hospital after an acute exacerbation of COPD.Standardizing the Pulmonary Embolism care with Pulmonary Embolism Response Teams (PERT)
This activity is intended for medical professionals who have a clinical interest in the management of pulmonary embolisms as seen by the following medical specialists: Pulmonologists, Hospitalists, Intensivists, Primary Care Providers, Internists, Physician Assistants, and Nurse Practitioners.Metered dose Nitrogen Cryospray for Treatment of Chronic Bronchitis in Patients with COPD (SPRAY-CB)
Gerard Criner, MD, FACP, FACCP, outlines the details of the SPRAY-BC clinical trial for the treatment of chronic bronchitis in patients with COPD.